| Prolactin modulator | |
|---|---|
| Drug class | |
 Bromocriptine, a D2 receptor agonist, and the most commonly used prolactin inhibitor | |
| Class identifiers | |
| Synonyms | Indirect prolactin modulator; Prolactin inhibitor; Prolactin releaser |
| Use | Hyperprolactinemia; Hypoprolactinemia |
| Biological target | D2 receptor (mainly) |
| Legal status | |
| In Wikidata | |
A prolactin modulator is a drug which affects the hypothalamic–pituitary–prolactin axis (HPP axis) by modulating the secretion of the pituitary hormone prolactin from the anterior pituitary gland. Prolactin inhibitors suppress and prolactin releasers induce the secretion of prolactin, respectively.[1][2]
- ^ Thomas L. Lemke; David A. Williams (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 432–. ISBN 978-1-60913-345-0.
- ^ University of Kansas School of Nursing Karen Wambach (15 August 2014). Breastfeeding and Human Lactation. Jones & Bartlett Publishers. pp. 182–. ISBN 978-1-4496-9729-7.
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search